RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE

Fresenius SE & Co KGaA ROE 2024

Fresenius SE & Co KGaA ROE

0

Fresenius SE & Co KGaA Dividend yield

3.18 %

Ticker

FRE.DE

ISIN

DE0005785604

WKN

578560

In 2024, Fresenius SE & Co KGaA's return on equity (ROE) was 0, a -100% increase from the 0.07 ROE in the previous year.

Fresenius SE & Co KGaA Aktienanalyse

What does Fresenius SE & Co KGaA do?

Fresenius SE is a German pharmaceutical and medical technology company, which was founded in 1912 by Eduard Fresenius. The company's history is marked by continuous growth and numerous acquisitions, which have shaped the current corporate structure. Fresenius operates in four different divisions: Fresenius Medical Care is a global leader in dialysis treatment and offers products as well as services related to dialysis. Fresenius Kabi specializes in the production of medications and medical devices for infusion and nutrition therapy. Fresenius Helios is one of the largest providers of hospital treatments with over 110 clinics and operates facilities in Germany, Spain, and Latin America. Fresenius Vamed offers services related to the management and planning of healthcare facilities and operates worldwide in over 85 countries. The business model of Fresenius SE is based on the development and production of innovative medical products, as well as the provision of services in the healthcare sector. The company relies on high-quality products and intensive research and development. A key factor for success is focusing on the needs of customers and patients to ensure the best possible care. One of the most well-known products of Fresenius SE are the Fresenius concentrates for dialysis treatment. These enable effective and gentle blood cleansing, thereby improving the quality of life for dialysis patients. Another example of innovative products are the 3-in-1 infusion systems by Fresenius Kabi. These combine the administration of fluids, medications, and nutrition into one system, offering significantly higher efficiency in patient care. Fresenius Helios focuses on patient-centered care and offers a wide range of medical services. The company operates both acute care clinics and long-term care facilities and utilizes state-of-the-art technologies to improve diagnosis and treatment. Fresenius Vamed provides its customers with services such as facility management, planning, and project management for healthcare facilities, as well as operational consulting. The comprehensive expertise in all areas of the healthcare industry ensures high quality in the implementation of construction projects and renovations. In summary, Fresenius SE is an internationally active company specializing in the provision of high-quality products and services in the healthcare sector. The company focuses on patient-centered care and the continuous development of innovative products and technologies. Fresenius SE & Co KGaA ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Fresenius SE & Co KGaA revenue by segment

In the annual report of the Fresenius SE & Co KGaA share (DE0005785604, 578560, FRE.DE), it breaks down its revenues into 4 segments: 1. Helios, 2. Kabi, 3. Vamed, 4. Medical Care. The Fresenius SE & Co KGaA stock (WKN: 578560, ISIN: DE0005785604, Ticker Symbol: FRE.DE) is a leading investment for investors interested in participating in the Health Care sector.

ROE Details

Decoding Fresenius SE & Co KGaA's Return on Equity (ROE)

Fresenius SE & Co KGaA's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Fresenius SE & Co KGaA's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Fresenius SE & Co KGaA's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Fresenius SE & Co KGaA’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Fresenius SE & Co KGaA Stock

What is the ROE (Return on Equity) of Fresenius SE & Co KGaA this year?

The ROE of Fresenius SE & Co KGaA this year is 0 undefined.

How has the Return on Equity (ROE) of Fresenius SE & Co KGaA developed compared to the previous year?

The ROE of Fresenius SE & Co KGaA has increased by -100% decreased compared to the previous year.

What impact does a high ROE (Return on Equity) have on investors of Fresenius SE & Co KGaA?

A high ROE indicates that Fresenius SE & Co KGaA generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.

What impact does a low ROE (Return on Equity) have on investors of Fresenius SE & Co KGaA?

A low ROE can indicate that Fresenius SE & Co KGaA is having difficulties monetizing its investments successfully and can be a negative signal for investors.

How does a change in the ROE (Return on Equity) of Fresenius SE & Co KGaA affect the company?

A change in ROE (Return on Equity) of Fresenius SE & Co KGaA can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.

How to calculate the ROE (Return on Equity) of Fresenius SE & Co KGaA?

The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.

Which factors influence the ROE (Return on Equity) of Fresenius SE & Co KGaA?

Some factors that can influence Fresenius SE & Co KGaA's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.

What strategic measures can take to improve the ROE (Return on Equity)?

To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.

How much dividend does Fresenius SE & Co KGaA pay?

Over the past 12 months, Fresenius SE & Co KGaA paid a dividend of 0.92 EUR . This corresponds to a dividend yield of about 3.18 %. For the coming 12 months, Fresenius SE & Co KGaA is expected to pay a dividend of 0.96 EUR.

What is the dividend yield of Fresenius SE & Co KGaA?

The current dividend yield of Fresenius SE & Co KGaA is 3.18 %.

When does Fresenius SE & Co KGaA pay dividends?

Fresenius SE & Co KGaA pays a quarterly dividend. This is distributed in the months of June, June, June, June.

How secure is the dividend of Fresenius SE & Co KGaA?

Fresenius SE & Co KGaA paid dividends every year for the past 25 years.

What is the dividend of Fresenius SE & Co KGaA?

For the upcoming 12 months, dividends amounting to 0.96 EUR are expected. This corresponds to a dividend yield of 3.32 %.

In which sector is Fresenius SE & Co KGaA located?

Fresenius SE & Co KGaA is assigned to the 'Health' sector.

Wann musste ich die Aktien von Fresenius SE & Co KGaA kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Fresenius SE & Co KGaA from 5/22/2023 amounting to 0.92 EUR, you needed to have the stock in your portfolio before the ex-date on 5/18/2023.

When did Fresenius SE & Co KGaA pay the last dividend?

The last dividend was paid out on 5/22/2023.

What was the dividend of Fresenius SE & Co KGaA in the year 2023?

In the year 2023, Fresenius SE & Co KGaA distributed 0.66 EUR as dividends.

In which currency does Fresenius SE & Co KGaA pay out the dividend?

The dividends of Fresenius SE & Co KGaA are distributed in EUR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Fresenius SE & Co KGaA stock can be added to a savings plan with the following providers: Trade Republic, ING, Scalable Capital and Consorsbank

Andere Kennzahlen von Fresenius SE & Co KGaA

Our stock analysis for Fresenius SE & Co KGaA Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Fresenius SE & Co KGaA Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.